Thalidomide and dexamethasone in patients with multiple myeloma not undergoing upfront autologous stem cell transplantation.
Blade
Joan
J
Hematology Unit, IDIBAPS, Hospital Clinic, Barcelona, Spain. jblade@clinic.ub.es
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D019090:Case Management; D016022:Case-Control Studies; D017322:Clinical Trials, Phase II as Topic; D003907:Dexamethasone / Q000008:administration & dosage; D006801:Humans; D009101:Multiple Myeloma / Q000188:drug therapy*; D036102:Peripheral Blood Stem Cell Transplantation; D013792:Thalidomide / Q000008:administration & dosage; D014182:Transplantation, Autologous; D016896:Treatment Outcome
D013792:Thalidomide; D003907:Dexamethasone